Literature DB >> 30738323

Increased cerebral blood volume in small arterial vessels is a correlate of amyloid-β-related cognitive decline.

Jun Hua1, SeungWook Lee2, Nicholas I S Blair2, Michael Wyss3, Jiri M G van Bergen4, Simon J Schreiner5, Sonja M Kagerer5, Sandra E Leh4, Anton F Gietl4, Valerie Treyer6, Alfred Buck7, Roger M Nitsch4, Klaas P Pruessmann3, Hanzhang Lu1, Peter C M Van Zijl1, Marilyn Albert8, Christoph Hock4, Paul G Unschuld9.   

Abstract

The protracted accumulation of amyloid-β (Aβ) is a major pathologic hallmark of Alzheimer's disease and may trigger secondary pathological processes that include neurovascular damage. This study was aimed at investigating long-term effects of Aβ burden on cerebral blood volume of arterioles and pial arteries (CBVa), possibly present before manifestation of dementia. Aβ burden was assessed by 11C Pittsburgh compound-B positron emission tomography in 22 controls and 18 persons with mild cognitive impairment (MCI), [ages: 75(±6) years]. After 2 years, inflow-based vascular space occupancy at ultra-high field strength of 7-Tesla was administered for measuring CBVa, and neuropsychological testing for cognitive decline. Crushing gradients were incorporated during MR-imaging to suppress signals from fast-flowing blood in large arteries, and thereby sensitize inflow-based vascular space occupancy to CBVa in pial arteries and arterioles. CBVa was significantly elevated in MCI compared to cognitively normal controls and regional CBVa related to local Aβ deposition. For both MCI and controls, Aβ burden and follow-up CBVa in several brain regions synergistically predicted cognitive decline over 2 years. Orbitofrontal CBVa was positively associated with apolipoprotein E e4 carrier status. Increased CBVa may reflect long-term effects of region-specific pathology associated with Aβ deposition. Additional studies are needed to clarify the role of the arteriolar system and the potential of CBVa as a biomarker for Aβ-related vascular downstream pathology.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  7 Tesla; Aging; Alzheimer's disease; Biomarker; CBV; Cerebral autoregulation; High field; Imaging; MRI; PET; Perfusion; Vascular

Mesh:

Substances:

Year:  2019        PMID: 30738323      PMCID: PMC6438210          DOI: 10.1016/j.neurobiolaging.2019.01.001

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  109 in total

1.  Brain amyloid burden and cerebrovascular disease are synergistically associated with neurometabolism in cognitively unimpaired older adults.

Authors:  Simon J Schreiner; Thomas Kirchner; Atul Narkhede; Michael Wyss; Jiri M G Van Bergen; Stephanie C Steininger; Anton Gietl; Sandra E Leh; Valerie Treyer; Alfred Buck; Klaas P Pruessmann; Roger M Nitsch; Christoph Hock; Anke Henning; Adam M Brickman; Paul G Unschuld
Journal:  Neurobiol Aging       Date:  2017-12-12       Impact factor: 4.673

2.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

3.  Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.

Authors:  Rune B Nielsen; Lærke Egefjord; Hugo Angleys; Kim Mouridsen; Michael Gejl; Arne Møller; Birgitte Brock; Hans Brændgaard; Hanne Gottrup; Jørgen Rungby; Simon F Eskildsen; Leif Østergaard
Journal:  Alzheimers Dement       Date:  2017-03-23       Impact factor: 21.566

4.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.

Authors:  Nathan A Johnson; Geon-Ho Jahng; Michael W Weiner; Bruce L Miller; Helena C Chui; William J Jagust; Maria L Gorno-Tempini; Norbert Schuff
Journal:  Radiology       Date:  2005-03       Impact factor: 11.105

5.  The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.

Authors:  Kentaro Hirao; Takashi Ohnishi; Yoko Hirata; Fumio Yamashita; Takeyuki Mori; Yoshiya Moriguchi; Hiroshi Matsuda; Kiyotaka Nemoto; Etsuko Imabayashi; Minoru Yamada; Toshihiko Iwamoto; Kunimasa Arima; Takashi Asada
Journal:  Neuroimage       Date:  2005-08-29       Impact factor: 6.556

Review 6.  Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease.

Authors:  David C Alsop; Weiying Dai; Murray Grossman; John A Detre
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 7.  Cerebrovascular effects of amyloid-beta peptides: mechanisms and implications for Alzheimer's dementia.

Authors:  Costantino Iadecola
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

Review 8.  Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

Authors:  Robert D Bell; Berislav V Zlokovic
Journal:  Acta Neuropathol       Date:  2009-03-25       Impact factor: 17.088

9.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

10.  Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.

Authors:  J M G van Bergen; X Li; J Hua; S J Schreiner; S C Steininger; F C Quevenco; M Wyss; A F Gietl; V Treyer; S E Leh; F Buck; R M Nitsch; K P Pruessmann; P C M van Zijl; C Hock; P G Unschuld
Journal:  Sci Rep       Date:  2016-10-17       Impact factor: 4.379

View more
  4 in total

1.  Impaired response of cerebral oxygen metabolism to visual stimulation in Huntington's disease.

Authors:  Peter Klinkmueller; Martin Kronenbuerger; Xinyuan Miao; Jee Bang; Kia E Ultz; Adrian Paez; Xiaoyu Zhang; Wenzhen Duan; Russell L Margolis; Peter Cm van Zijl; Christopher A Ross; Jun Hua
Journal:  J Cereb Blood Flow Metab       Date:  2020-08-17       Impact factor: 6.200

2.  Differential Changes in Arteriolar Cerebral Blood Volume between Parkinson's Disease Patients with Normal and Impaired Cognition and Mild Cognitive Impairment (MCI) Patients without Movement Disorder - An Exploratory Study.

Authors:  Adrian G Paez; Chunming Gu; Suraj Rajan; Xinyuan Miao; Di Cao; Vidyulata Kamath; Arnold Bakker; Paul G Unschuld; Alexander Y Pantelyat; Liana S Rosenthal; Jun Hua
Journal:  Tomography       Date:  2020-12

3.  Local Functional MR Change Pattern and Its Association With Cognitive Function in Objectively-Defined Subtle Cognitive Decline.

Authors:  Liang Cui; Zhen Zhang; Chun-Yi Zac Lo; Qihao Guo
Journal:  Front Aging Neurosci       Date:  2021-06-11       Impact factor: 5.750

4.  Huntingtin silencing delays onset and slows progression of Huntington's disease: a biomarker study.

Authors:  Hongshuai Liu; Chuangchuang Zhang; Jiadi Xu; Jing Jin; Liam Cheng; Xinyuan Miao; Qian Wu; Zhiliang Wei; Peiying Liu; Hanzhang Lu; Peter C M van Zijl; Christopher A Ross; Jun Hua; Wenzhen Duan
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.